Immune Repertoire Sequencing Market Growth Analysis and Opportunity 2018-2026

Immune Repertoire Sequencing Market Size,
Share, Trend, Outlook, Future Growth
Analysis And Synthesis 2018 - 2026
Immune repertoire sequencing is extensively used in biomarker discovery to improve the success rate
and cost-effectiveness of rational drug development. For instance, in November, 2017, the Center for
Commercialization of Cancer Immunotherapy (C3i) started offering T cell receptor-beta sequencing
services in its Biomarker and Diagnostic unit in Canada. Increasing demand for personalized medicine, in
turn, is expected to aid the immune repertoire sequencing market growth, as personalized medicine uses
an individual’s genetic profile to guide decisions made in regard to the diagnosis, prevention, and
treatment of diseases.
The global immune repertoire sequencing market size was valued at US$ 114.3 million in 2017, and is
expected to witness a CAGR of 5.6% over the forecast period (2018 – 2026).
Free Request Sample of Report:
Increasing Research & Development and Demand for Genomic and Repertoire Sequencing-based Research
is expected to Drive Growth of the Immune Repertoire Sequencing Market
Increasing research and development and launches of novel products by key players are expected to be
the major driving force for global immune repertoire sequencing market growth in the near future. For
instance, in 2016, ArcherDX, Inc. expanded its product portfolio with the launch of Archer Immunoverse
immune repertoire sequencing assays at the American Society of Hematology (ASH). In 2017, ArcherDX,
Inc. launched Archer Immunoverse B Cell Receptor (BCR) assays to characterize the human B cell
According to a study published by Cold Spring Harbor Laboratory, in 2017, researchers from Stanford
University applied immune repertoire sequencing to identify disease-related signatures in the immune
systems of patients with systemic sclerosis-related pulmonary hypertension (SSc-PAH), a rare chronic
autoimmune disease that affects the connective tissue. Therefore, increasing research on immune
repertoire sequencing is expected to create a favorable environment for immune repertoire sequencing
market growth in the near future.
Immune Repertoire Sequencing Market - Regional Insights
On the basis of region, the global immune repertoire sequencing market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to
hold a dominant position in the global immune repertoire sequencing market during the forecast period,
owing to high presence of key industry players in the region (including Illumina Inc., Thermo Fisher
Scientific, Pacific Biosciences, and CD Genomics). These players are increasingly focusing on development
of novel technologies for immune repertoire sequencing. For instance, in 2017, 10x Genomics Inc., U.S.
based company, added B-Cell and 5’Unbiased Enrichment Kit to its chromium immune repertoire
profiling solution or immune repertoire sequencing.
Report includes chapters which deeply display the following deliverable about industry :
• Immune Repertoire Sequencing Market Research Objective and Assumption
• Immune Repertoire Sequencing Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Immune Repertoire Sequencing Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Immune Repertoire Sequencing Market, By Regions
• Immune Repertoire Sequencing Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Immune Repertoire Sequencing Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Immune Repertoire Sequencing Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Immune Repertoire Sequencing Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Immune Repertoire Sequencing Market - Competitive Landscape
Key players operating in the global immune repertoire sequencing market include Thermo Fisher
Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics,
Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent
Technologies, Inc., and Takara Bio, Inc.
Detailed Segmentation:
Global Immune Repertoire Sequencing Market, By Product Type:
Assay Kits
- T-Cell Receptor (TCR) Kits
- B-Cell Receptor (BCR) Kits
Global Immune Repertoire Sequencing Market, By Application:
Cancer Immunotherapy
Biomarker Discovery
Autoimmune Diseases
Vaccine Development and Efficacy
Transplant Rejection and Tolerance
Infectious Diseases
Other Applications
Find the comprehensive research report here with a single click:
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

The global immune repertoire sequencing market size was valued at US$ 114.3 million in 2017, and is expected to witness a CAGR of 5.6% By 2026.